Authors: Swaak, AJG van de Brink, H Smeenk, RJT Manger, K Kalden, JR Tosi, S Marchesoni, A Domljan, Z Rozman, B Logar, D Pokorny, G Kovacs, L Kovacs, A Vlachoyiannopoulos, PG Moutsopoulos, HM Chwalinska-Sadowska, H Dratwianka, B Kiss, E Cikes, N Anic, B Schneider, M Fischer, R Bombardieri, S Mosca, M Graninger, W Smolen, JS

Citation: Ajg. Swaak et al., Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies including Therapeutic Trials (ESCISIT), RHEUMATOLOG, 40(1), 2001, pp. 89-94

Authors: Swaak, AJG van den Brink, HG Smeenk, RJT Manger, K Kalden, JR Tosi, S Domljan, Z Rozman, B Logar, D Pokorny, G Kovacs, L Kovacs, A Vlachoyiannopoulos, PG Moutsopoulos, HM Chwalinska-Sadowska, H Kiss, E Cikes, N Anic, B Schneider, M Fischer, R Bombardieri, S Mosca, M Graninger, W Smolen, JS

Citation: Ajg. Swaak et al., Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation, LUPUS, 10(1), 2001, pp. 51-58

Authors: Swaak, AJG van den Brink, HG Smeenk, RJT Manger, K Kalden, JR Tosi, S Marchesoni, A Domljan, Z Rozman, B Logar, D Pokorny, G Kovacs, L Kovacs, A Vlachoyiannopoulos, PG Moutsopoulos, HM Chwalinska-Sadowska, H Dratwianka, B Kiss, E Cikes, N Branimir, A Schneider, M Fischer, R Bombardieri, S Mosca, M Graninger, W Smolen, JS

Citation: Ajg. Swaak et al., Systemic lupus erythematosus: clinical features in patients with a diseaseduration of over 10 years, first evaluation, RHEUMATOLOG, 38(10), 1999, pp. 953-958

Authors: Jelakovic, B Benkovic, J Cikes, N Kuzmanic, D Cvoriscec, D Ceovic, S Roncevic, T Krznaric, Z

Citation: B. Jelakovic et al., Antibodies to Tamm-Horsfall protein in endemic nephropathy, NEPH DIAL T, 14(11), 1999, pp. 2645-2649